Back to results
US 11,926,574 B2Granted
Dimethoxyphenylalkylamine activators of serotonin receptors
AssigneeAtai Therapeutics, Inc.
InventorsGlenn Short, Robert B. Perni, Benjamin Robert Difrancesco, Tanweer A. Khan
Life of this patent
Estimating the term…
Abstract
Provided herein are compounds of Formula (I), or pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, and n are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I) or pharmaceutically acceptable salt thereof, and methods of using a compound of Formula (I) or pharmaceutically acceptable salt thereof, e.g., in the treatment of a mental health disease or disorder.
Claims21
A compound of Formula (II-B):
- or a pharmaceutically acceptable salt thereof;
- wherein,
- R1 is independently at each position hydrogen, C1-C6 alkyl, or C1-C6 haloalkyl;
- R2 and R3 are independently hydrogen, heterocycle, C1-C6 alkyl, C1-C6 haloalkyl, halogen, cyano, OR1, S(O)(═NH)R1, S(O)2R1, S(O)R1 or SR1, wherein at least one of R2 and R3 is hydrogen;
- R4 is C1-C6 alkyl;
- and
- R5 is halogen.
4 more elements
Dependencies are inferred from the claim text.